Table 7.
Summary of adverse event incidence after 12 weeks of treatment: Number (%) of safety evaluable patients
PARAMETER |
CLIN/RA GEL n=1008 |
CLINDAMYCIN GEL n=1002 |
---|---|---|
Patients with at least one AE | 270 (26.8) | 236 (23.6) |
Total number of AEs | 409 | 387 |
Patients with at least one serious AE | 2 (0.2) | 3 (0.3) |
Patients with at least one severe AE | 4 (0.4) | 9 (0.9) |
Patients with at least one treatment-related AE | 42 (4.2) | 17 (1.7) |
Patients discontinued due to an AE | 7 (0.7) | 4 (0.4) |
- AE
- adverse event